Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-25-018125

Options or other derivatives

  • Chief Executive Officer acquired 960,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
MacBeath Gavin Chief Executive Officer 2024-01-12 Grant or award · Stock Option (Right to Buy) +160,000 160,000 D: show line 1 in the form
MacBeath Gavin Chief Executive Officer 2025-01-03 Grant or award · Stock Option (Right to Buy) +800,000 800,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…